Healionics raises $4.7M to commercialize artificial blood vessel tech

15 May, 2021

Healionics raises $4.7M to commercialize artificial blood vessel tech
Photo by JOHN TOWNER on Unsplash

– Seattle-based medical technology company Healionics raised $4.7m funding.
– The round was led by Keiretsu Capital and joined by others.
– It will be used to complete a second human study and obtain FDA clearance.

Biotechnology Health Care Medical Medical Device North America
Crunchbase icon

Content report

The following text will be sent to our editors: